| Family: | State Street (SPDR) |
| Name: | SPDR S&P Pharmaceuticals ETF |
| Inception Date: | 19-Jun-2006 |
| Termination Date: | |
| Investment Objective: | The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ). |
| Prospectus | |
| Top 10 Holdings | ||
| CORCEPT THERAPEUTICS INC | CORT | 4.1962% |
| ORGANON + CO | OGN | 3.7890% |
| LIQUIDIA CORP | LQDA | 3.0668% |
| AXSOME THERAPEUTICS INC | AXSM | 2.7990% |
| DEFINIUM THERAPEUTICS INC | DFTX | 2.2608% |
| JAZZ PHARMACEUTICALS PLC | JAZZ | 2.2444% |
| HARMONY BIOSCIENCES HOLDINGS | HRMY | 2.2335% |
| AMNEAL PHARMACEUTICALS INC | AMRX | 2.1845% |
| ENLIVEN THERAPEUTICS INC | ELVN | 2.1843% |
| ROYALTY PHARMA PLC CL A | RPRX | 2.1163% |
| Top 10 Holdings Weight: | 27.1% |
| Number of Holdings: | 60 |
| Shares Outstanding: | 6,050,270 |
| Total Net Assets: | 361,624,600 |
| NAV: | 59.85 |
| Net Expense Ratio: | 0.35% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Pharmaceuticals |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
